Your browser doesn't support javascript.
loading
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?
Sánchez-Salinas, Mario Andrés; Miarons, Marta; Troconiz, Iñaki F; Navarro, Víctor; Varela, Javier; Iacoboni, Gloria; Barba, Pere.
Afiliação
  • Sánchez-Salinas MA; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Miarons M; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Troconiz IF; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Navarro V; Pharmacy Department, Consorci Hospitalari de Vic, Barcelona, Spain.
  • Varela J; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
  • Iacoboni G; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Barba P; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Blood Adv ; 8(9): 2130-2132, 2024 May 14.
Article em En | MEDLINE | ID: mdl-38231085

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Imunoterapia Adotiva Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Imunoterapia Adotiva Idioma: En Ano de publicação: 2024 Tipo de documento: Article